Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lornoxicam in mild to moderate probable Alzheimer's disease
2009-011098-34Phase 2Completed
- Sponsor
- JSW LifeSciences
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Alzheimer's disease (AD) comparing Lornoxicam with Placebo (2 arms). Primary endpoint: ADAS-cog+. Started Jun 2009; status: completed.
02
Drugs
lornoxicam
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2009-011098-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011098-34.